Google DeepMind and Isomorphic Labs have formalized a joint bioresilience initiative designed to bolster global defenses against both natural infectious disease outbreaks and engineered biological threats. Following a twelve-month period of development, the companies announced over fifteen new partnerships with government agencies, biosecurity organizations, and academic institutions to operationalize advanced artificial intelligence for biological risk mitigation. The program is structured around three core operational domains: prevention, detection, and response. The prevention layer enforces a rigorous safety protocol that integrates threat modeling, continuous system evaluation, mitigation strategies, and active monitoring. The organizations are simultaneously adapting their SynthID watermarking technology to the biological sector, enabling DNA synthesis providers to screen for and flag AI-generated sequence data that may pose safety risks. Detection capabilities are being enhanced through AI-driven optimization of metagenomic sequencing pipelines. The AlphaEvolve agent streamlines the analysis of genomic data, significantly reducing the cost and time required for large-scale pathogen surveillance. Concurrently, tools such as AlphaGenome and automated protein function annotation are deployed to rapidly identify novel genetic markers and emerging biological threats beyond traditional diagnostic thresholds. On the response front, vetted researchers and public health authorities are receiving priority access to DeepMind’s generative AI systems and Isomorphic Labs’ Drug Design Engine to accelerate the development of vaccines and therapeutic countermeasures. A dedicated response unit at Isomorphic Labs ensures these platforms can be rapidly scaled during novel outbreaks, directly supporting the creation of diagnostics and treatments for both naturally occurring pandemics and potential bioterrorism scenarios. The initiative operates in alignment with the companies’ Chemical, Biological, Radiological, and Nuclear risk management frameworks and their broader Frontier Safety protocols. By building upon prior scientific breakthroughs, including AlphaFold’s comprehensive mapping of protein structures, the joint program aims to shift global health infrastructure from reactive crisis management to proactive biological defense. Leadership at both organizations emphasized that securing the global health ecosystem against advanced biological risks will require transparent, ongoing collaboration with biosecurity laboratories, regulatory bodies, and the wider scientific community to ensure responsible AI deployment.